News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,932 Results
Type
Article (56237)
Company Profile (385)
Press Release (709310)
Multimedia
Podcasts (85)
Webinars (13)
Section
Business (219269)
Career Advice (2337)
Deals (37932)
Drug Delivery (113)
Drug Development (85380)
Employer Resources (182)
FDA (17288)
Job Trends (16215)
News (370377)
Policy (35759)
Tag
Academia (2906)
Accelerated approval (5)
Adcomms (25)
Allergies (91)
Alliances (54489)
ALS (94)
Alzheimer's disease (1468)
Antibody-drug conjugate (ADC) (140)
Approvals (17282)
Artificial intelligence (316)
Autoimmune disease (24)
Automation (16)
Bankruptcy (382)
Best Places to Work (12349)
BIOSECURE Act (20)
Biosimilars (114)
Biotechnology (268)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (295)
Cancer (2364)
Cardiovascular disease (192)
Career advice (1967)
Career pathing (33)
CAR-T (166)
Cell therapy (461)
Cervical cancer (21)
Clinical research (69080)
Collaboration (898)
Company closure (1)
Compensation (543)
Complete response letters (23)
COVID-19 (2811)
CRISPR (47)
C-suite (260)
Cystic fibrosis (107)
Data (2256)
Decentralized trials (2)
Denatured (34)
Depression (51)
Diabetes (284)
Diagnostics (6775)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (143)
Drug pricing (114)
Drug shortages (30)
Duchenne muscular dystrophy (96)
Earnings (90217)
Editorial (42)
Employer branding (23)
Employer resources (157)
Events (121939)
Executive appointments (762)
FDA (18617)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (802)
Gene editing (115)
Generative AI (31)
Gene therapy (330)
GLP-1 (803)
Government (4808)
Grass and pollen (5)
Guidances (67)
Healthcare (20319)
Huntington's disease (23)
IgA nephropathy (30)
Immunology and inflammation (129)
Indications (30)
Infectious disease (2962)
Inflammatory bowel disease (149)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (100)
Interviews (367)
IPO (17179)
IRA (43)
Job creations (4316)
Job search strategy (1673)
Kidney cancer (11)
Labor market (38)
Layoffs (518)
Leadership (20)
Legal (8840)
Liver cancer (80)
Lung cancer (332)
Lymphoma (158)
Machine learning (7)
Management (63)
Manufacturing (332)
MASH (70)
Medical device (14523)
Medtech (14528)
Mergers & acquisitions (21310)
Metabolic disorders (747)
Multiple sclerosis (84)
NASH (17)
Neurodegenerative disease (104)
Neuropsychiatric disorders (32)
Neuroscience (2046)
NextGen: Class of 2025 (7190)
Non-profit (4870)
Now hiring (39)
Obesity (399)
Opinion (244)
Ovarian cancer (76)
Pain (94)
Pancreatic cancer (85)
Parkinson's disease (158)
Partnered (21)
Patents (244)
Patient recruitment (115)
Peanut (50)
People (62066)
Pharmaceutical (84)
Pharmacy benefit managers (21)
Phase I (21596)
Phase II (30281)
Phase III (22605)
Pipeline (1229)
Policy (150)
Postmarket research (2842)
Preclinical (9370)
Press Release (72)
Prostate cancer (109)
Psychedelics (33)
Radiopharmaceuticals (267)
Rare diseases (409)
Real estate (6641)
Recruiting (68)
Regulatory (24321)
Reports (47)
Research institute (2590)
Resumes & cover letters (391)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (78)
Series A (140)
Series B (89)
Service/supplier (17)
Sickle cell disease (55)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (32)
Startups (4035)
State (2)
Stomach cancer (14)
Supply chain (73)
Tariffs (40)
The Weekly (49)
Vaccines (763)
Venture capitalists (43)
Weight loss (278)
Women's health (38)
Worklife (17)
Date
Last 7 days (926)
Last 30 days (2585)
Last 365 days (34599)
2025 (11510)
2024 (37170)
2023 (41937)
2022 (53297)
2021 (58053)
2020 (56937)
2019 (50093)
2018 (37980)
2017 (35029)
2016 (35165)
2015 (41234)
2014 (35000)
2013 (30336)
2012 (32689)
2011 (33229)
2010 (31761)
Location
Africa (878)
Alabama (56)
Alaska (7)
Arizona (254)
Arkansas (14)
Asia (43493)
Australia (7368)
California (6319)
Canada (2050)
China (553)
Colorado (278)
Connecticut (297)
Delaware (156)
Europe (96433)
Florida (927)
Georgia (217)
Idaho (63)
Illinois (594)
India (26)
Indiana (321)
Iowa (11)
Japan (167)
Kansas (109)
Kentucky (26)
Louisiana (11)
Maine (70)
Maryland (946)
Massachusetts (4830)
Michigan (244)
Minnesota (414)
Mississippi (2)
Missouri (90)
Montana (30)
Nebraska (25)
Nevada (65)
New Hampshire (69)
New Jersey (1778)
New Mexico (31)
New York (1797)
North Carolina (1060)
North Dakota (9)
Northern California (2737)
Ohio (210)
Oklahoma (15)
Oregon (41)
Pennsylvania (1407)
Puerto Rico (13)
Rhode Island (35)
South America (1293)
South Carolina (24)
South Dakota (1)
Southern California (2363)
Tennessee (104)
Texas (931)
United States (24172)
Utah (190)
Virginia (155)
Washington D.C. (66)
Washington State (589)
West Virginia (3)
Wisconsin (60)
765,932 Results for "enteric medical technologies inc acquired by boston scientific".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.
June 18, 2024
·
7 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
January 8, 2025
·
7 min read
Deals
Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
Silk Road Medical, Inc. announced it has entered into a definitive agreement to be acquired by Boston Scientific Corporation, a global medical technology leader, for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.
June 18, 2024
·
7 min read
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
November 25, 2024
·
7 min read
Deals
Boston Scientific Announces Agreement to Acquire Axonics, Inc.
Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.
January 8, 2024
·
8 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
November 5, 2024
·
7 min read
Press Releases
Boston Scientific announces upcoming investor conference schedule
May 2, 2025
·
1 min read
Press Releases
Boston Scientific announces results for first quarter 2025
April 23, 2025
·
19 min read
Deals
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company.
September 19, 2023
·
6 min read
1 of 76,594
Next
